14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today TNXP ranks #14195 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Tonix Pharmaceuticals Holding Corp. Stock Forecast NASDAQ:TNXP

$0.45 (3.43%)

Volume: 11M

Closed: Dec 08, 2021

Hollow Logo Score: -1.903

Tonix Pharmaceuticals Holding Corp. Stock Forecast

$0.45 (3.43%)

Volume: 11M

Closed: Dec 08, 2021

Score Hollow Logo -1.903
Which way will TNXP go? Request
Key Stats
Beta 1.53
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 20 - 80 ] RSI14 is 35 and the stock is currently not being overbought or oversold

Tonix Pharmaceuticals Holding Corp. stock price up 3.43% on Wednesday
(Updated on Dec 08, 2021)

Sell candidate since 2021-12-08

The Tonix Pharmaceuticals Holding Corp. stock price gained 3.43% on the last trading day (Wednesday, 8th Dec 2021), rising from $0.43 to $0.45. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 6.63% from a day low at $0.42 to a day high of $0.45. The price has fallen in 6 of the last 10 days and is down by -8.58% for this period. Volume fell on the last day by -6 million shares and in total, 11 million shares were bought and sold for approximately $4.96 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -24.85% during the next 3 months and, with a 90% probability hold a price between $0.30 and $0.40 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are mixed signals in the stock today. The Tonix Pharmaceuticals Holding Corp. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.52. On a fall, the stock will find some support from the short-term average at $0.43. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). A buy signal was issued from a pivot bottom point on Monday, December 06, 2021, and so far it has risen 8.93%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss

Tonix Pharmaceuticals Holding Corp. finds support from accumulated volume at $0.43 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0279 between high and low, or 6.63%. For the last week, the stock has had a daily average volatility of 7.28%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Tonix Pharmaceuticals Holding Corp. stock A Buy?

Tonix Pharmaceuticals Holding Corp. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.903

Predicted Opening Price for Tonix Pharmaceuticals Holding Corp. of Thursday, December 9, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 9, 2021 Current price
$0.44 $0.45 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 11, 2021 "Alliance Global Partners" gave "$4.00 - $2.00" rating for TNXP. The price target was set to $0.78+10.8%.

Volatility and Risk
Daily Average Volatility: 7.28 %
Overall Risk: Very High High Medium Low Very Low
7.28 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.48
Price: $0.45
Support: $0.43

TNXP Insider Trading Show all Trades



Last 100 transactions
Buy: 12 268 895 | Sell: 40 000 (Shares)
Date Action Amount Person Type
Sep 28, 2021 Buy 12 000 Lederman Seth Common Stock, $0.001 par value
Jul 16, 2021 Buy 237 437 Taylor Carolyn E. Stock Option
May 25, 2021 Buy 5 000 Goodman Daniel Wintner Common Stock
May 10, 2021 Buy 270 882 Treco James Stock Option
May 10, 2021 Buy 270 882 Goodman Daniel Wintner Stock Option
Show all Insider Trades


Last 100 transactions
Buy: 12 268 895 | Sell: 40 000 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.47 4.56 %
0.46 2.17 %
0.45 0.69 %
Current price: 0.45
Support 0.43 -4.08 %
0.42 -5.56 %
0.41 -7.95 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.49 9.39 %
0.48 6.92 %
0.48 6.57 %
Current price 0.45
Support 0.43 -3.32%
0.43 -4.35%
0.41 -8.20%

Click to get the best stock tips daily for free!

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Tonix Pharmaceuticals Holding Corp. engages in developing medicines for common disorders of the central nervous system. These disorders are characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. The company's lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, which is in Phase III clinical stage for the treatment of fibromyalgia; and Phase ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE